3.21.2 html 340 328 1 false 76 0 false 12 false false R1.htm 0001001 - Document - Cover Sheet http://www.sangamo.com/role/Cover Cover Cover 1 false false R2.htm 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 3 false false R4.htm 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Statements 4 false false R5.htm 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 2101101 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 2107102 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 8 false false R9.htm 2112103 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES Sheet http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES CASH EQUIVALENTS AND MARKETABLE SECURITIES Notes 9 false false R10.htm 2117104 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE Sheet http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE BASIC AND DILUTED NET LOSS PER SHARE Notes 10 false false R11.htm 2119105 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES Sheet http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES Notes 11 false false R12.htm 2128106 - Disclosure - INCOME TAXES Sheet http://www.sangamo.com/role/INCOMETAXES INCOME TAXES Notes 12 false false R13.htm 2130107 - Disclosure - COMMITMENTS Sheet http://www.sangamo.com/role/COMMITMENTS COMMITMENTS Notes 13 false false R14.htm 2135108 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.sangamo.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 14 false false R15.htm 2138109 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.sangamo.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS' EQUITY Notes 15 false false R16.htm 2140110 - Disclosure - ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. Sheet http://www.sangamo.com/role/ACQUISITIONOFSANGAMOTHERAPEUTICSFRANCESAS ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. Notes 16 false false R17.htm 2144111 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.sangamo.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 17 false false R18.htm 2202201 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Policies) Sheet http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Policies) Policies 18 false false R19.htm 2303301 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Tables) Sheet http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Tables) Tables http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 19 false false R20.htm 2308302 - Disclosure - FAIR VALUE MEASUREMENTS - (Tables) Sheet http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables FAIR VALUE MEASUREMENTS - (Tables) Tables http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS 20 false false R21.htm 2313303 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables) Sheet http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables) Tables http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES 21 false false R22.htm 2320304 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - (Tables) Sheet http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - (Tables) Tables http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES 22 false false R23.htm 2331305 - Disclosure - COMMITMENTS - (Tables) Sheet http://www.sangamo.com/role/COMMITMENTSTables COMMITMENTS - (Tables) Tables http://www.sangamo.com/role/COMMITMENTS 23 false false R24.htm 2336306 - Disclosure - STOCK-BASED COMPENSATION - (Tables) Sheet http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION - (Tables) Tables http://www.sangamo.com/role/STOCKBASEDCOMPENSATION 24 false false R25.htm 2341307 - Disclosure - ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. - (Tables) Sheet http://www.sangamo.com/role/ACQUISITIONOFSANGAMOTHERAPEUTICSFRANCESASTables ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. - (Tables) Tables http://www.sangamo.com/role/ACQUISITIONOFSANGAMOTHERAPEUTICSFRANCESAS 25 false false R26.htm 2404401 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Sheet http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Details 26 false false R27.htm 2405402 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration Agreements and Research Activity Grants (Detail) Sheet http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration Agreements and Research Activity Grants (Detail) Details 27 false false R28.htm 2406403 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Detail) Sheet http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Detail) Details 28 false false R29.htm 2409404 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Fair Value Measurements of Cash Equivalents, Available-for-Sale Marketable Securities and Free Share Asset/Liability (Detail) Sheet http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSSummaryofFairValueMeasurementsofCashEquivalentsAvailableforSaleMarketableSecuritiesandFreeShareAssetLiabilityDetail FAIR VALUE MEASUREMENTS - Summary of Fair Value Measurements of Cash Equivalents, Available-for-Sale Marketable Securities and Free Share Asset/Liability (Detail) Details 29 false false R30.htm 2410405 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Detail) Sheet http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSNarrativeDetail FAIR VALUE MEASUREMENTS - Narrative (Detail) Details 30 false false R31.htm 2411406 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Estimated Fair Value of Free Shares Valuation Assumptions (Detail) Sheet http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSSummaryofEstimatedFairValueofFreeSharesValuationAssumptionsDetail FAIR VALUE MEASUREMENTS - Summary of Estimated Fair Value of Free Shares Valuation Assumptions (Detail) Details 31 false false R32.htm 2414407 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Detail) Sheet http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Detail) Details 32 false false R33.htm 2415408 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of cost and estimated fair value of short-term investments (Details) Sheet http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of cost and estimated fair value of short-term investments (Details) Details 33 false false R34.htm 2416409 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Additional Information (Detail) Sheet http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetail CASH EQUIVALENTS AND MARKETABLE SECURITIES - Additional Information (Detail) Details 34 false false R35.htm 2418410 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE - Additional Information (Detail) Sheet http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREAdditionalInformationDetail BASIC AND DILUTED NET LOSS PER SHARE - Additional Information (Detail) Details 35 false false R36.htm 2421411 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Detail) Sheet http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Detail) Details 36 false false R37.htm 2422412 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Detail) Sheet http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Detail) Details 37 false false R38.htm 2423413 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Detail) Sheet http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Detail) Details 38 false false R39.htm 2424414 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Detail) Sheet http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Detail) Details 39 false false R40.htm 2425415 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Detail) Sheet http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Detail) Details http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables 40 false false R41.htm 2426416 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Sanofi S.A. (Detail) Sheet http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Sanofi S.A. (Detail) Details http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables 41 false false R42.htm 2427417 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - California Institute for Regenerative Medicine (Detail) Sheet http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESCaliforniaInstituteforRegenerativeMedicineDetail MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - California Institute for Regenerative Medicine (Detail) Details 42 false false R43.htm 2429418 - Disclosure - INCOME TAXES (Details) Sheet http://www.sangamo.com/role/INCOMETAXESDetails INCOME TAXES (Details) Details http://www.sangamo.com/role/INCOMETAXES 43 false false R44.htm 2432419 - Disclosure - COMMITMENTS - Additional Information (Detail) Sheet http://www.sangamo.com/role/COMMITMENTSAdditionalInformationDetail COMMITMENTS - Additional Information (Detail) Details 44 false false R45.htm 2433420 - Disclosure - COMMITMENTS - Summary of Maturities of Operating Lease Liabilities (Detail) Sheet http://www.sangamo.com/role/COMMITMENTSSummaryofMaturitiesofOperatingLeaseLiabilitiesDetail COMMITMENTS - Summary of Maturities of Operating Lease Liabilities (Detail) Details 45 false false R46.htm 2434421 - Disclosure - COMMITMENTS - Non-cancelable Material Contractual Commitments (Detail) Sheet http://www.sangamo.com/role/COMMITMENTSNoncancelableMaterialContractualCommitmentsDetail COMMITMENTS - Non-cancelable Material Contractual Commitments (Detail) Details 46 false false R47.htm 2437422 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Detail) Sheet http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Detail) Details 47 false false R48.htm 2439423 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Detail) Sheet http://www.sangamo.com/role/STOCKHOLDERSEQUITYNarrativeDetail STOCKHOLDERS' EQUITY - Narrative (Detail) Details 48 false false R49.htm 2442424 - Disclosure - ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. - Narrative (Detail) Sheet http://www.sangamo.com/role/ACQUISITIONOFSANGAMOTHERAPEUTICSFRANCESASNarrativeDetail ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. - Narrative (Detail) Details http://www.sangamo.com/role/ACQUISITIONOFSANGAMOTHERAPEUTICSFRANCESASTables 49 false false R50.htm 2443425 - Disclosure - ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. - Summary of Non-controlling Interest (Detail) Sheet http://www.sangamo.com/role/ACQUISITIONOFSANGAMOTHERAPEUTICSFRANCESASSummaryofNoncontrollingInterestDetail ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. - Summary of Non-controlling Interest (Detail) Details 50 false false R51.htm 2445426 - Disclosure - SUBSEQUENT EVENTS - Additional Information (Detail) Sheet http://www.sangamo.com/role/SUBSEQUENTEVENTSAdditionalInformationDetail SUBSEQUENT EVENTS - Additional Information (Detail) Details 51 false false All Reports Book All Reports sgmo-20210930.htm sgmo-20210930.xsd sgmo-20210930_cal.xml sgmo-20210930_def.xml sgmo-20210930_lab.xml sgmo-20210930_pre.xml sgmo-20210930xex101_employ.htm sgmo-20210930xex312.htm sgmo-20210930xex321.htm sgmo-20210931xex311.htm sgmo-20210930_g1.jpg sgmo-20210930_g2.jpg http://xbrl.sec.gov/dei/2021 http://fasb.org/srt/2021-01-31 http://fasb.org/us-gaap/2021-01-31 true true